Welcome to Our New Website!
Overview
Each year, the Conference Forum holds the R&D Leadership Summit®, a private event for primarily senior-level R&D executives and CEOs from mid to large pharma and biotech companies, to address timely and relevant issues impacting R&D decision-making. The 2024 dates are March 4-5 at the Eau Palm Beach in Malapan, Florida. The 2023 theme was largely focused on the future of R&D, leading through unprecedented times.
Huge thanks to lead advisors Fred Hassan, Managing Director, Healthcare, Warburg Pincus, Thomas Koestler, PhD, Executive Director, Vatera Health Care Partners, Mathai Mammen, MD, PhD, CEO, FogPharma, Alise Reicin, MD, CEO, Tectonic Therapeutics, Mark Simon, Advisor, Stifel, and Ron Cohen, MD, President and CEO, Acorda Therapeutics for their guidance and support on the program agenda.
We are grateful for the support and participation
from advisors and attendees
Anna D Barker, PhD, FAACR
Chief Strategy Officer, The Ellison Institute
Roy Baynes, MD, PhD
EVP and Chief Medical Officer, Eikon Therapeutics, Inc
Kim Branson, PhD
SVP Global Head of Artificial Intelligence and Machine Learning, GSK
Jeffrey Berkowitz
CEO and Director, Real Endpoints
Melissa Bonner, PhD
SVP, Former Head of Research, bluebird bio
Ron Cohen, MD, PhD
President and CEO, Acorda Therapeutics
Rena Conti, PhD
Associate Professor, Markets, Public Policy and Law, Boston University Questrom School of Business
Steve Cutler, PhD
CEO, ICON
Robert M. Davis
Chairman and CEO, Merck
Shobha Dhadda, PhD
SVP, Global Head, Biostatistics & Project Operations, ADBH, Eisai Inc.
Mikael Dolsten, MD, PhD
Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer Inc.
Laura Esserman, MD, MBA
Director, UCSF Breast Care Center
Professor of Surgery & Radiology, University of California, San Francisco
Steve Frank
Chairman of Global Healthcare Investment Banking, JP Morgan
Keith Gottesdiener, MD
President & CEO, Prime Medicine
Fred Hassan
Managing Director, Healthcare, Warburg Pincus
Rachel Haurwitz, PhD
President & CEO, Caribou Biosciences
Katherine A. High, MD
Visiting Professor, Rockefeller University
Axel Hoos, MD, PhD
CEO, Scorpion Therapeutics
Kjel Johnson, PharmD
Vice President, Specialty Pharmacy Strategy, CVS Health
Dina Katabi, PhD
Director, MIT Center for Wireless Networks and Mobile Computing
Najat Khan, PhD
Chief Data Science Officer and Global Head Strategy & Operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson
Lynn D. Kramer, MD, FAAN
Chief Clinical Officer ADBH and Corporate Officer, Eisai Co., Ltd.
John Lepore, MD
CEO, Profound Therapeutics
Roger Longman
Founder & Chairman, Real Endpoints
Johan Luthman, PhD
EVP, Head of R&D, Lundbeck
Mathai Mammen, MD, PhD
CEO, FogPharma
Chronis Manolis, RPh
SVP, Pharmacy Services, Chief Pharmacy Officer, UPMC Insurance Services Division
Clive Meanwell, MD
Chairman and Partner, Population Health Partners
Bill Mezzanotte, MD, MPH
EVP, Head of R&D and Chief Executive Officer, CSL
Mark McKenna
Former Chairman and CEO, Prometheus Biosciences
Ajay Nirula, MD, PhD
SVP, Immunology, Site Head, Lilly Biotechnology Center San Diego, Eli Lilly & Company
Joseph Papa
CEO, Bausch+Lomb
Roger Perlmutter, MD, PhD
Chairman & CEO, Eikon Therapeutics, Inc
Karen Peterson
Patient Advocate
Andy Plump, MD, PhD
President, R&D, Takeda
Sylke Poehling, PhD
SVP and Global Head, Therapeutic Modalities, Pharma Research & Early Development, Roche
Sumant Ramachandra, MD, PhD
CEO & President, ImmPACT Bio
John Reed, MD, PhD
EVP Global Head of R&D, Sanofi
David Reese, MD
EVP, R&D, Amgen
Alise Reicin, MD
CEO & President, Tectonic Therapeutics
Mark Simon, MBA
Advisor, Stifel
Mary Szela
CEO and President, TriSalus Life Sciences
Philip Tagari
CSO, insitro
Lambert van der Walde
SVP, Executive Director, Center for Health Care Research, UnitedHealth Group
Michael Yee
Managing Director, Jefferies LLC
Tal Zaks, MD, PhD
Venture Partner, Orbimed
Elias Zerhouni, MD
Emeritus Professor, Johns Hopkins University
We are grateful for the support
and participation from past keynotes
Kenneth Frazier
Chairman of the Board and CEO, Merck & Co
Robert Bradway
CEO, Amgen
Joaquin Duato
Chairman, Pharmaceuticals, JnJ
Daphne Koller, PhD
Founder & CEO, insitro
George Yancopoulos, MD, PhD
Co-Founder, President & CSO, Regeneron
Bahija Jallal, PhD
former CEO, MedImmune
Deborah Dunsire, MD
Former CEO, Lundbeck
Vas Narasimhan, MD
CEO, Novartis
Rupert Vessey, DPhil
Chief Scientist, Executive Partner, Flagship Pioneering
Scott Gottlieb, MD
23rd Commissioner, U.S. Food and Drug Administration
CNBC Contributor
Lars Rebien Sorensen
former CEO, Novo Nordisk
Brent Saunders
former CEO, Allergan
Many thanks to the executive team at ICON for all their support and to the entire speaking faculty, who brought their vast experience together to identify and collaborate over ideas that will advance therapeutics for the benefit of patients.
Our guests are as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change to advance R&D and to provide support for the leaders behind the movement.
For questions about the R&D Leadership Summit, please contact Tracey Kimball at Tracey@tcfllc.org or Valerie Bowling at Valerie@tcfllc.org.
